From October 30, 2023 to December 31, 2023, the company has repurchased 506,300 shares, representing 0.25% for CNY 20.02 million. With this, the company has completed the repurchase of 506,300 shares, representing 0.25% for CNY 20.02 million under the buyback announced on October 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29.09 CNY | -1.39% | -7.15% | -25.92% |
Jun. 07 | PharmaBlock Sciences, Inc. Announces Dividend on Share A for the Year 2023, Payable on June 14, 2024 | CI |
May. 20 | PharmaBlock Sciences, Inc. Approves Cash Dividend for the Year 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.92% | 798M | |
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
+11.88% | 216B | |
-0.78% | 219B | |
+5.90% | 164B |
- Stock Market
- Equities
- 300725 Stock
- News PharmaBlock Sciences (Nanjing), Inc.
- Tranche Update on PharmaBlock Sciences, Inc.'s Equity Buyback Plan announced on October 31, 2023.